Poole Ahn Amanda, EVP and Chief Human Resources Officer at Bristol-Myers Squibb (BMY), has exclusively engaged in selling activity over 24 reported transactions, all involving BMY stock, with no recorded purchases. The total sell value amounts to $193,740.21, with the most recent transactions occurring on March 10, 2026, and March 10, 2024. The largest single sale took place on March 10, 2026, valued at $75,523.28, followed by two additional sales the same day totaling $22,067.71 and $22,187.97. Earlier, on March 10, 2024, Poole executed three sales worth $52,499.04, $11,134.53, and $10,327.68.
The filings indicate a consistent pattern of disposition, with no offsetting buys, suggesting a net reduction in Poole’s BMY holdings over time. The transactions, coded as "F" (indicating discretionary sales) and interspersed with "A," "J," and "M" (typically representing grants or option exercises with no immediate monetary value), reflect a focus on liquidating vested equity. While the sales are spread across two years, the absence of any buying activity points to a one-sided approach. The dollar amounts, though not exceptionally large, collectively represent a meaningful divestment, with the most recent sales in 2026 accounting for over half the total value. The data does not indicate whether these sales are part of a prearranged trading plan.
AI-assisted summary